RESULTS &CONCLUSIONS:Incentive measures should be taken to drive the growth of the big pharma enterprises,and usher the small-and-medium enterprises...

• 结果与结论:应当推动有实力的企业做大做强,引导中小型制药企业做精做专;利用资源,再造优势;加大技术创新力度。